Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > N-Cinnamoylated Aminoquinolines as Promising Antileishmanial Agents
Publication

Publications

N-Cinnamoylated Aminoquinolines as Promising Antileishmanial Agents

Title
N-Cinnamoylated Aminoquinolines as Promising Antileishmanial Agents
Type
Article in International Scientific Journal
Year
2013
Authors
Vale Costa, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Costa Gouveia, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Perez, B
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Silva, T
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Teixeira, C
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Gomes, MS
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 57
Pages: 5112-5115
ISSN: 0066-4804
Scientific classification
FOS: Medical and Health sciences > Basic medicine
Other information
Authenticus ID: P-006-6Z9
Abstract (EN): A series of cinnamic acid conjugates of primaquine and chloroquine were evaluated for their in vitro antileishmanial activities. Although primaquine derivatives had modest activity, chloroquine conjugates exhibited potent activity against both promastigotes (50% inhibitory concentration [IC50] = 2.6 to 21.8 mu M) and intramacrophagic amastigotes (IC50 = 1.2 to 9.3 mu M) of Leishmania infantum. Both the high activity of these chloroquine analogues and their mild-to-low toxicity toward host cells make them promising leads for the discovery of new antileishmanial agents.
Language: English
Type (Professor's evaluation): Scientific
License type: Click to view license CC BY-NC
Documents
File name Description Size
ART_80 203.29 KB
Related Publications

Of the same journal

Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance (2017)
Another Publication in an International Scientific Journal
Nuno Vale; Gouveia, MJ; Rinaldi, G; Brindley, PJ; Gartner, F; da Costa, JMC
Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital (2007)
Another Publication in an International Scientific Journal
Sandra Quinteira; Filipa Grosso; Helena Ramos; Luisa Peixe
GES-14-Producing Acinetobacter baumannii Isolates in a Neonatal Intensive Care Unit in Tunisia Are Associated with a Typical Middle East Clone and a Transferable Plasmid (2017)
Another Publication in an International Scientific Journal
Mabrouk, A; Grosso, F; Botelho, J; Achour, W; Ben Hassen, A; Luisa Peixe
First isolation of bla(VIM-2) in an environmental isolate of Pseudomonas pseudoalcaligenes (2005)
Another Publication in an International Scientific Journal
Quinteira, S; Ferreira, H; Peixe, L
Environmental KPC-Producing Escherichia coli Isolates in Portugal (2012)
Another Publication in an International Scientific Journal
poirel, l; barbosa-vasconcelos, a; simoes, rr; da costa, pm; liu, w; nordmann, p

See all (55)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-10 at 20:44:45 | Privacy Policy | Personal Data Protection Policy | Whistleblowing